Production (Stage)
OptimizeRx Corporation
OPRX
$12.19
-$0.45-3.56%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.20M | -78.00K | -9.12M | -4.01M | -6.90M |
| Total Depreciation and Amortization | 1.00M | 1.56M | 1.00M | 1.00M | 996.00K |
| Total Amortization of Deferred Charges | 265.00K | 55.00K | 274.00K | 253.00K | 253.00K |
| Total Other Non-Cash Items | 1.56M | 4.40M | 8.47M | 2.90M | 3.16M |
| Change in Net Operating Assets | 3.24M | -5.75M | 1.17M | 633.00K | 4.61M |
| Cash from Operations | 3.86M | 198.00K | 1.79M | 782.00K | 2.12M |
| Capital Expenditure | -27.00K | -17.00K | -18.00K | -45.00K | -32.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -57.00K | -103.00K | -74.00K | -40.00K | -121.00K |
| Cash from Investing | -84.00K | -120.00K | -92.00K | -85.00K | -153.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -500.00K | -2.50M | -500.00K | -500.00K | -500.00K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -87.00K | -324.00K | -32.00K | -415.00K | -140.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -587.00K | -2.82M | -532.00K | -915.00K | -640.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.19M | -2.75M | 1.17M | -218.00K | 1.33M |